1. Introduction {#sec1-nutrients-12-00493}
===============

While coffee consumption has increased globally, the research on biological function and effects of coffee intake remain controversial \[[@B1-nutrients-12-00493]\]. A meta-analysis of randomized controlled trials stated that coffee intake changed blood lipid profiles, including increase of cholesterol and triglyceride (TG) \[[@B2-nutrients-12-00493]\], which are clinical indicators for cardiovascular disease risk. On the contrary, other meta-analysis on observational and interventional studies suggested that high coffee consumption was associated with reduced risks of cardiovascular disease and mortality \[[@B3-nutrients-12-00493],[@B4-nutrients-12-00493],[@B5-nutrients-12-00493]\].

Genetic variation has been suggested as one of the main reasons why individuals respond differently to coffee intake \[[@B6-nutrients-12-00493]\]. Focused studies have been conducted on the ADORA locus and its genetic variants because their expression is antagonized by caffeine and, in turn, play a role in transmitting the effects of coffee intake throughout the body \[[@B7-nutrients-12-00493]\].

Studies investigating the association between coffee intake and the ADORA gene family have focused on neuronal effects such as habitual coffee intake \[[@B8-nutrients-12-00493]\], arousal \[[@B9-nutrients-12-00493]\], sleep disorders \[[@B10-nutrients-12-00493]\], and anxiety \[[@B11-nutrients-12-00493]\], or on blood pressure \[[@B6-nutrients-12-00493]\]. The *ADORA* gene family, composed of *ADORA1*, *ADORA2A*, *ADORA2B*, and *ADORA3*, are differently expressed in a tissue-specific manner and show unique properties in regulating multiple physiological statuses \[[@B7-nutrients-12-00493]\]. A recent review highlighted that the *ADORA* gene members are modulators of lipid availability \[[@B12-nutrients-12-00493]\]. The physiological role of the ADORAs has been reported to be associated with lipid-related diseases, including cardiovascular disease \[[@B13-nutrients-12-00493]\], coronary blood flow \[[@B14-nutrients-12-00493]\], chronic heart failure \[[@B15-nutrients-12-00493]\], atherosclerosis, and dyslipidemia \[[@B16-nutrients-12-00493]\].

While the association of the *ADORA* gene family between coffee intake and multiple lipid-related diseases have been investigated in several studies, we hypothesized that the discrepancies in the findings of coffee intake with regard to dyslipidemia might be explained by genetic variants, which henceforth motivated this study.

2. Materials and Methods {#sec2-nutrients-12-00493}
========================

2.1. Study Population {#sec2dot1-nutrients-12-00493}
---------------------

This study was conducted with a local community-based cohort emanating from the Korean population-based cohorts of the Korean Genome and Epidemiology Study \[[@B17-nutrients-12-00493]\]. The local community-based cohort included residents living in rural Ansung and urban Ansan since 2001. All subjects provided informed consent at baseline. The cohort was examined by follow-up surveys every two years, and the eighth follow-up survey was performed in 2018. This study used data from the second follow-up survey conducted from 2005 to 2006.

From a total of 7515 subjects, aged 43--74 years, we excluded 2617 subjects with missing data, those with daily energy consumption \<500 kcal or \>4500 kcal, those with previous history and presence of diabetes, renal disease, thyroid disease, cardiovascular disease, cancer, hysterectomy, and ovariectomy, and those who received medications for those diseases. Finally, 2527 male and 2371 female subjects were included in this study ([Figure 1](#nutrients-12-00493-f001){ref-type="fig"}).

Dyslipidemia was defined as dyslipidemia diagnosis, related drug use, and abnormal lipid profile (low-density lipoprotein-cholesterol ≥ 160 mg/dL, TG ≥ 200 mg/dL, total cholesterol (TC) ≥ 240 mg/dL, and high-density lipoprotein-cholesterol \<40 mg/dL). Blood pressure was the average of three measurements with five minutes interval, taken in the morning after 10 min of rest in sitting position. Coffee intake was assessed using the food-frequency questionnaire. Depending on the amounts of coffee intake per week, the subjects were divided into those who consumed less than one cup of coffee per day (low coffee intake group) and those who consumed more than or equal to one cup of coffee per day (high coffee intake group). A cup was estimated as much as 150 mL. This study was approved by the Institutional Review Board of Ewha Womans University, Seoul, Korea (IRB No. 129-17).

2.2. Genotyping and Analysis of Single Nucleotide Polymorphisms {#sec2dot2-nutrients-12-00493}
---------------------------------------------------------------

Genomic DNA was collected from peripheral blood samples of the subjects and genotyped on Affymetrix Genome-Wide Human SNP Array 5.0, as previously described \[[@B18-nutrients-12-00493]\]. Among SNPs in four loci encoding ADORAs, 79 SNPs were included in the platform. The missing call rate (\>5%), deviation from Hardy--Weinberg equilibrium (HWE) (*p* \< 1 × 10^6^), or minor allele frequency (*p* \< 0.05) was used to eliminate 38 inadequate SNPs in the sample population. Among the remaining 38 SNPs, 30 SNPs were removed due to high levels of pairwise linkage disequilibrium (LD) ([Figure 2](#nutrients-12-00493-f002){ref-type="fig"}). Finally, eight of the 79 SNPs were used for further analysis ([Table 1](#nutrients-12-00493-t001){ref-type="table"}).

2.3. Statistical Analysis {#sec2dot3-nutrients-12-00493}
-------------------------

Statistical analyses were performed using the SAS program (SAS 9.4, 2016, SAS Institute, Cary, NC, USA). Data are presented as mean with standard deviation (SD). The numbers in brackets are percentages in the column. To compare differences between groups, we used Student's *t*-test for numeric variables after log transformation and the chi-square test for categorical variables. Odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate te associations among variables by using logistic regression analysis. OR and 95% CI were adjusted with the following confounders: age, marital status, income, education, smoking behavior, energy intake, systolic blood pressure, and body mass index (BMI) in male subjects and age, income, education, drinking behavior, smoking behavior, energy intake, BMI, menopause, female hormone treatment, and hypertension in female subjects. The *p*-value for the interaction between genetics and coffee intake was calculated. Findings were considered significant at *p* \< 0.05. Calculation of allele frequencies and HWE and variant pruning based on LD were conducted using the software package PLINK v1.09 \[[@B19-nutrients-12-00493]\]. Pairwise LD blocks of genetic variants in the ADORA gene family were produced by Haploview 4.2 \[[@B20-nutrients-12-00493]\]. After testing different genetic models, including dominant, recessive, and additive models, the recessive model was selected for this study.

3. Results {#sec3-nutrients-12-00493}
==========

3.1. Basic Characteristics Depending on Coffee Consumption {#sec3dot1-nutrients-12-00493}
----------------------------------------------------------

[Table 2](#nutrients-12-00493-t002){ref-type="table"} shows the basic characteristics of the subjects according to sex and the amount of coffee intake. In both male and female subjects, those in the high coffee intake group were younger, had a higher income, had a longer duration of education, and were more frequently current smokers when compared with the findings in the low coffee intake group. Energy consumption was higher in the high coffee intake group than in the low coffee intake group. Additionally, the high coffee intake group showed a significantly lower consumption of sugar and the proportion of carbohydrates in energy distribution when compared with the findings in the low coffee intake group.

In contrast, the mean intake of fat was higher in the high coffee intake group than in the low coffee intake group, and the finding was in accordance with an increased ratio of energy distribution. Systolic blood pressure was lower in the high coffee intake group than in the low coffee intake group. However, hip circumference, height, and weight were higher in the high coffee intake group than in the low coffee intake group. Among both male and female subjects, the TC level was higher in the high coffee intake group than in the low coffee intake group. However, the TG level was higher among male subjects and lower among female subjects in the high coffee intake group than in the low coffee intake group. Among female subjects, the prevalence of hypertension and menopause were lower in the high coffee intake group than in the low coffee intake group.

3.2. Association of Coffee Intake with the Risk of Dyslipidemia {#sec3dot2-nutrients-12-00493}
---------------------------------------------------------------

We next examined the effect of coffee intake on dyslipidemia risk. There was an inverse correlation between coffee intake and the prevalence of dyslipidemia in female subjects (OR: 0.768, 95% CI: 0.645--0.914, *p* = 0.0030) but not in male subjects (*p* = 0.2635) after adjusting for confounders ([Table 3](#nutrients-12-00493-t003){ref-type="table"}).

3.3. Effects of Coffee Intake on the Risk of Dyslipidemia Depending on ADORA Gene Family {#sec3dot3-nutrients-12-00493}
----------------------------------------------------------------------------------------

Finally, we performed a logistic regression analysis to confirm the genetic effect of the *ADORA* gene family on the association between coffee intake and dyslipidemia risk ([Table 4](#nutrients-12-00493-t004){ref-type="table"} and [Table 5](#nutrients-12-00493-t005){ref-type="table"}). Interestingly, among female subjects, a favorable effect of consuming more coffee on dyslipidemia risk showed only those with the minor alleles of *ADORA1* rs10800901 (OR: 0.727, 95% CI: 0.560--0.944, *p* = 0.0168), and *ADORA2B* rs2779212 (OR: 0.645, 95% CI: 0.506--0.823, *p* = 0.0004) and the major alleles of *ADORA3* rs2786967 (OR: 0.818, 95% CI: 0.676--0.989, *p* = 0.0384), but not in those with alternative alleles. Among male subjects, there was instead an increased dyslipidemia risk on consuming more coffee carrying the minor alleles of *ADORA2A* rs57604223 (OR: 1.352, 95% CI: 1.014--1.802, *p* = 0.0402). Male subjects with the minor allele of *ADORA3A* rs3393 also showed lower risk on dyslipidemia ([Table S1](#app1-nutrients-12-00493){ref-type="app"}), and the favorable effects did not occur when they consumed more coffee. Overall, these results indicate that the effect of coffee intake on dyslipidemia risk depends on genetic variants in the *ADORA* gene family in a sex-specific manner.

4. Discussion {#sec4-nutrients-12-00493}
=============

The present study aimed to investigate whether genetic variants in the *ADORA* gene family influence the effect of coffee intake on dyslipidemia risk. Coffee intake was associated with decreased dyslipidemia risk in female subjects but not in male subjects. Furthermore, with regard to the genetic effect on the association, the favorable effect of coffee intake among female subjects depends on a subset of genetic variants in *ADORA* gene family. The risk of dyslipidemia was also increased among male subjects in the high coffee intake group based on genetic variation of the *ADORA* gene family, indicating that a subset of genetic variants in the *ADORA* gene family modulates the effect of coffee intake on dyslipidemia risk in a sex-specific manner.

The *ADORA* gene family has been reported to play a role in regulating the lipid profile \[[@B12-nutrients-12-00493]\]. For instance, ADORA1 deficiency in ApoE KO mice was associated with increased plasma lipid levels \[[@B22-nutrients-12-00493]\], and *ADORA2B* knockout mice showed increased TG and TC levels compared to the wildtype \[[@B23-nutrients-12-00493]\]. Disturbed lipid levels via modulation of *ADORA2B* also influenced the development of dyslipidemia and atherosclerosis, known risk factors of cardiovascular mortality \[[@B16-nutrients-12-00493]\]. ADORA2B also showed a close relationship with cholesterol regulation by formation of foam cells and inflammation, which are mediator of cardiovascular disease \[[@B13-nutrients-12-00493],[@B16-nutrients-12-00493]\]. In addition to the functional relevance of the ADORAs in blood lipid profiles and lipid-related chronic diseases, a genetic variant of *ADORA2A* showed association with the severity of chronic heart failure in Asians \[[@B15-nutrients-12-00493]\]. The evidence proposed that variations in the ADORA gene family might influence lipid regulation and cardiovascular disease. We also observed a subset of genetic variants in the *ADORA* gene family associated with the risk of dyslipidemia ([Table S1](#app1-nutrients-12-00493){ref-type="app"}).

Despite the interesting finding of an association between the *ADORA* gene family and dyslipidemia itself, the novelty here is that the ADORAs modulates the effect of coffee intake on dyslipidemia. A meta-analysis showed coffee intake increase blood lipid level \[[@B2-nutrients-12-00493]\], but not all of the included studies satisfied the result \[[@B3-nutrients-12-00493],[@B4-nutrients-12-00493],[@B5-nutrients-12-00493]\]. We identified different effects of coffee intake in the risk of dyslipidemia linked to their genetic variants in the *ADORA* gene family. Even though there was no association between coffee intake and dyslipidemia in male, we confirmed the increased risk of dyslipidemia when subjects with the minor allele of rs5760423 in *ADORA2A* consumed more than one cup of coffee. While we did not experimentally examine the association, instead only focusing on the association of genetic variants in *ADORA* gene family with coffee intake in dyslipidemia, we identified a subset of genetic variants in the *ADORA* gene family located at regulatory elements which could play a role as eQTLs influencing gene expression in various tissues \[[@B24-nutrients-12-00493]\] ([Table 1](#nutrients-12-00493-t001){ref-type="table"}). Indeed, a recent study suggested that genetic variation could contribute to altered gene expression by changing epigenetic enhancer activity, which, in turn, is linked to five different vascular diseases \[[@B25-nutrients-12-00493]\]. Given the previous reports, genetic variants in ADORA gene family might modify gene expression through epigenetic regulation, possibly modulating the lipid profile and the effect of coffee intake in dyslipidemia pathogenesis. Further studies are needed to elucidate their possible functional mechanisms.

We also observed a favorable association between coffee intake and the prevalence of dyslipidemia in female subjects but not in male subjects. Inconsistent results of coffee intake between male and female individuals \[[@B26-nutrients-12-00493],[@B27-nutrients-12-00493]\], including a Korean population \[[@B28-nutrients-12-00493]\], obscure the view. Female individuals responded favorably to coffee concerning cardiovascular health. It has been proposed that the female sex hormone estrogen plays a role in the sensitivity of female individuals to the effects of coffee intake \[[@B29-nutrients-12-00493]\]. Estrogen is synthesized from cholesterol in the ovary, and it influences lipid metabolism by increasing lipoprotein lipase activity and is directly interacting with specific estrogen receptors in the adipose tissue. Thus, susceptibility to cardiovascular diseases is lower in premenopausal women than in men of the same age and postmenopausal women \[[@B30-nutrients-12-00493]\]. A previous finding that coffee intake increases the concentration of estrogen in Asian female individuals could explain the sex-specific differences in the effect of coffee intake on dyslipidemia \[[@B29-nutrients-12-00493]\].

The most interesting of our findings is that increased coffee intake had beneficial effects in female subjects but harmful effects in male subjects significantly associated with a subset of genetic variants in the *ADORA* gene family. This could suggest that the response to environmental factors of the ADORAs differs according to sex. Several previous studies showed different influences of environmental factors related to the *ADORA* genotypes depending on sex. Treatment with the ADORA antagonist ATL444 was shown to have a preventive effect on cocaine addiction in male individuals but not in female individuals \[[@B31-nutrients-12-00493]\]. Additionally, locomotor activity in response to administration of caffeine was higher in male WT mice than in male *ADORA2A* knockout mice, however, this difference was not noted in female mice. Although the reason why the *ADORA* genotype causes a difference in the environmental response depending on sex is not known, a possible explanation may be that dopamine receptor 2 (D2) and the ADORA2A system are more sensitive in female than in male individuals \[[@B32-nutrients-12-00493],[@B33-nutrients-12-00493]\]. Dopamine signaling has been suggested as a therapeutic target of dyslipidemia, showing cardioprotective effects \[[@B32-nutrients-12-00493]\]. Caffeine treatment has been shown to increase the expression of D2 protein in female but not in male individuals \[[@B33-nutrients-12-00493]\]. Based on our data, we suggest that not only do D2 but also the ADORAs modulate the environmental response of the sex-specific physiological mechanism.

We found a novel gene-environment interaction of the *ADORA* genetic variants and coffee intake on dyslipidemia in a Korean population. However, further, larger studies are warranted to replicate the findings. In addition, while our study did not consider how subjects consumed coffee and how much caffeine was present owing to the limited information in the original cohort, we appreciate the importance of further studies including those parameters. Although it has been reported that the addition of milk, the type of coffee bean, and the type of roasting method do not alter antioxidant activity \[[@B34-nutrients-12-00493]\], it may be important to consider these factors to perform an in-depth analysis. Lastly, our analysis did not consider physical activity as a confounding factor, although it has been shown to influence blood lipid profiles \[[@B35-nutrients-12-00493],[@B36-nutrients-12-00493]\]. Additional confounding factors, such as physical activity, may need to be considered for further analysis.

5. Conclusions {#sec5-nutrients-12-00493}
==============

This study demonstrated that a subset of genetic variants in the *ADORA* gene family influences the association between coffee intake and dyslipidemia risk in a sex-specific manner. As a first study to elucidate the effect of coffee intake on dyslipidemia risk in terms of genetic variability in the *ADORA* gene family, important avenues of detailed research are available. This includes deep understanding of the functional mechanisms on the genetic variants in the *ADORA* gene family in response to coffee intake, potentially aiding prevention and management of dyslipidemia among individuals vulnerable to the disease.

Data in this study were from the Korean Genome and Epidemiology Study (KoGES; 4851-302). National Research Institute of Health, Centers for Disease Control and Prevention, Ministry for Health and Welfare, Republic of Korea.

The following are available online at <https://www.mdpi.com/2072-6643/12/2/493/s1>, Table S1. Association between genetic variants in ADORA gene family and the risk of dyslipidemia.

###### 

Click here for additional data file.
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![A flow chart of subject selection.](nutrients-12-00493-g001){#nutrients-12-00493-f001}

![Linkage Disequilibrium (LD) block of genetic variants in the *Adenosine Receptor* (*ADORA*) gene family. The LD blocks are for variants in (**a**) *ADORA1*, (**b**) *ADORA2A*, (**c**) *ADORA2B*, and (**d**) *ADORA3* loci, respectively. Square boxes indicate SNPs used for further analysis.](nutrients-12-00493-g002){#nutrients-12-00493-f002}

nutrients-12-00493-t001_Table 1

###### 

The list of selected SNPs in the *Adenosine Receptor* (*ADORA*) gene family.

  Gene        SNP ID       Chr   Physical Position   Location   Regulatory Element   Alleles ^1^   MAF      HWE
  ----------- ------------ ----- ------------------- ---------- -------------------- ------------- -------- --------
  *ADORA1*    rs10800899   1     203081125           intron                          A/G           0.1607   0.2697
              rs6701725          203102728           intron                          A/G           0.1735   0.1381
              rs10800901         203111304           intron                          G/A           0.4486   0.7471
  *ADORA2A*   rs5760423    22    24840118            intron                          T/G           0.4439   0.2536
  *ADORA2B*   rs17715109   17    15869557            intron     H3K4me1, Dnase1      T/G           0.0517   0.5145
              rs2779212          15876655            intron     H3K4me1, eQTL        C/T           0.2287   0.4510
  *ADORA3*    rs3393       1     112042149           UTR-3      Dnase1               T/C           0.4457   0.7306
              rs2786967          112075948           intron                          G/A           0.8891   0.8767

^1^ Alleles are presented as minor/major alleles. SNP, single nucleotide polymorphism; Chr, chromosome; MAF, minor allele frequency; HWE, Hardy--Weinberg equilibrium.

nutrients-12-00493-t002_Table 2

###### 

Basic Characteristics depending on the amount of coffee intake in male and female ^1^.

                                         Male                Female                                                              
  -------------------------------------- ------------------- ------------------ ---------- ------------------ ------------------ ----------
  Age (year)                             56.62 ± 8.90        53.95 ± 8.13       \<0.0001   57.28 ± 8.75       54.55 ± 8.73       \<0.0001
  Marriage ^3^                                                                                                                   
    Married                              798 (95.34)         1639 (96.98)       0.0361     939 (84.44)        1071 (85.07)       0.6725
  Monthly income (×10^4^ KRW)                                                                                                    
    Low (\<100)                          251 (29.99)         351 (20.77)        \<0.0001   524 (47.12)        468 (37.17)        \<0.0001
    Medium (100--199)                    199 (23.78)         356 (21.07)                   268 (24.10)        254 (20.17)        
    High (≥200)                          387 (46.24)         983 (58.17)                   320 (28.78)        537 (42.65)        
  Education (year)                                                                                                               
    Low (0--6)                           217 (25.93)         313 (18.52)        \<0.0001   619 (55.67)        508 (40.35)        \<0.0001
    Medium ((7--9)                       171 (20.43)         348 (20.59)                   222 (19.96)        264 (20.97)        
    High (≥10)                           449 (53.64)         1029 (60.89)                  271 (24.37)        487 (36.68)        
  Alcohol drinking behavior                                                                                                      
    Never                                154 (18.40)         335 (19.82)        0.6875     869 (78.15)        817 (64.89)        \<0.0001
    Former                               70 (8.36)           136 (8.05)                    22 (1.98)          19 (1.51)          
    Current                              613 (73.24)         1219 (72.13)                  221 (19.87)        423 (33.60)        
  Alcohol intake (g/day) ^4^             25.77 ± 36.07       25.00 ± 31.27      0.5934     3.99 ± 8.89        4.88 ± 11.01       \<0.0001
  Smoking behavior                                                                                                               
    Never                                287 (34.29)         346 (20.47)        \<0.0001   1094 (98.38)       1219 (96.82)       0.0489
    Former                               304 (36.32)         642 (37.99)                   5 (0.45)           12 (0.95)          
    Current                              246 (29.39)         702 (41.54)                   13 (1.17)          28 (2.22)          
  Tobacco consumption (pack/years) ^5^   16.61 ± 14.57       20.25 ± 18.42      \<0.0001   7.38 ± 6.04        7.42 ± 8.31        0.0289
  Nutrient intakes                                                                                                               
    Energy (Kcal)                        1,772.21 ± 510.35   1984.88 ± 527.16   \<0.0001   1594.52 ± 497.34   1753.07 ± 532.77   \<0.0001
    Sugar (g/per 1000 Kcal)              180.35 ± 16.89      177.75 ± 14.54     \<0.0001   186.28 ± 16.97     182.06 ± 15.48     \<0.0001
    Fat (g/per 1000 Kcal)                14.72 ± 5.89        16.44 ± 5.13       \<0.0001   12.68 ± 5.89       14.85 ± 5.44       \<0.0001
    Protein (g/per 1000 Kcal)            32.52 ± 5.93        32.48 ± 5.13       0.8755     31.88 ± 5.30       32.44 ± 5.97       0.0269
  Energy distribution (%)                                                                                                        
    Carbohydrate                         73.35 ± 7.20        71.93 ± 6.13       \<0.0001   75.56 ± 7.32       73.47 ± 6.63       \<0.0001
    Fat                                  13.44 ± 5.31        14.94 ± 4.61       \<0.0001   11.53 ± 5.29       13.45 ± 4.85       \<0.0001
    Protein                              13.21 ± 2.35        13.13 ± 2.03       0.4204     12.91 ± 2.45       13.07 ± 2.33       0.0946
  SBP (mmHg)                             117.73 ± 15.80      116.12 ± 14.87     0.0147     116.00 ± 17.26     113.95 ± 16.84     0.0030
  DBP (mmHg)                             79.74 ± 10.11       79.18 ± 10.10      0.1838     76.61 ± 10.37      75.58 ± 10.53      0.0131
  Waist circumference (cm)               84.22 ± 7.76        84.77 ± 7.46       0.0692     83.98 ± 9.68       82.76 ± 9.45       0.0022
  Hip circumference (cm)                 90.90 ± 5.23        92.32 ± 5.21       \<0.0001   91.13 ± 5.35       92.18 ± 5.25       \<0.0001
  Height (cm)                            166.32 ± 5.95       167.15 ± 5.83      0.0008     153.23 ± 5.84      153.94 ± 5.63      0.0026
  Weight (kg)                            65.71 ± 9.27        68.04 ± 9.57       \<0.0001   57.55 ± 8.45       58.76 ± 8.03       0.0004
  BMI (kg/m^2^) ^6^                                                                                                              
    Underweight (\<18.5)                 26 (3.11)           29 (1.72)          0.0003     18 (1.62)          15 (1.19)          0.0739
    Normal (18.5--22.9)                  290 (34.65)         502 (29.70)                   364 (32.73)        356 (28.28)        
    Overweight (23--24.9)                253 (30.23)         485 (28.70)                   284 (25.54)        356 (28.28)        
    Obese (≥25)                          268 (32.02)         674 (39.88)                   446 (40.11)        532 (42.26)        
  HbA1C (%)                              5.41 ± 0.41         5.41 ± 0.39        0.9575     5.47 ± 0.40        5.44 ± 0.40        0.0628
  Total cholesterol (mg/dL)              183.12 ± 34.42      191.06 ± 32.64     \<0.0001   193.01 ± 34.56     196.65 ± 33.53     0.0060
  HDL-Cholesterol (mg/dL)                43.90 ± 10.86       43.04 ± 10.24      0.0614     44.83 ± 9.77       46.75 ± 10.16      \<0.0001
  Triglyceride (mg/dL)                   144.81 ± 107.99     150.9 ± 117.12     0.0385     124.89 ± 69.71     116.24 ± 66.91     0.0001
  Menopause                                                                                789 (70.95)        712 (56.55)        \<0.0001
  Female hormone treatment                                                                 25 (2.25)          34 (2.70)          0.4804
  Hypertension ^7^                       259 (30.94)         482 (28.52)        0.2079     367 (33.00)        333 (26.45)        0.0005

^1^ Data are presented as the means ± SDs or n (%). ^2^ Statistical significance was calculated with Student's *t*-tests for continuous variables after log transformation and chi-square tests for categorical variables. ^3^ Married included married and cohabitation. ^4^ Data were collected from current alcohol consumers without missing responders; *n* = 610, 1216 in male and 220, 421 in female, respectively. ^5^ Data were collected from former and current smokers without missing responders; *n* = 189, 372 in male and 13, 24 in female, respectively. ^6^ Degree of obesity was categorized into four stages according to the criterion of World Health Organization (WHO) Asia-Pacific Area \[[@B21-nutrients-12-00493]\]. ^7^ Subjects with diagnosis in medical history.

nutrients-12-00493-t003_Table 3

###### 

Associations between coffee intake and the risk of dyslipidemia.

  Coffee      Male          Female                                                                                           
  ----------- ------------- ------------- ---------------------- -------- ------------- ------------- ---------------------- --------
  \<1 cup/d   427 (35.14)   410 (31.25)   1                               571 (42.93)   541 (51.97)   1                      
  ≥1 cup/d    788 (64.86)   902 (68.75)   1.107 (0.926--1.323)   0.2635   759 (57.07)   500 (48.03)   0.768 (0.645--0.914)   0.0030

^1^ Adjusted for age, marital status, income, education, smoking behavior, energy intake, systolic blood pressure, and BMI. ^2^ Adjusted for age, income, education, drinking and smoking behavior, energy intake, BMI, menopause, treatment of female hormone, and hypertension. ^3^ Odds ratio (OR), 95% confidence interval (95% CI), and statistical significance were calculated with logistic regression analysis. DLP, dyslipidemia.

nutrients-12-00493-t004_Table 4

###### 

Risk of dyslipidemia depending on the coffee intake and genotype in ADORA gene family in male.

  Genes           Alleles   Coffee Intake   Healthy       Dyslipidemia   Adjusted Model ^1^               
  --------------- --------- --------------- ------------- -------------- ----------------------- -------- --------
  ***ADORA1***                                                                                            
  rs10800899      GG        \<1 cup/d       299 (24.61)   274 (20.88)    1                                0.8839
                            ≥1 cup/d        541 (44.53)   641 (48.86)    1.176 (0.952--1.453)    0.1327   
                  AG/AA     \<1 cup/d       128 (10.53)   136 (10.37)    1.103 (0.816--1.493)    0.5231   
                            ≥1 cup/d        247 (20.33)   261 (19.89)    1.064 (0.828--1.368)    0.6267   
  rs6701725       GG        \<1 cup/d       294 (24.20)   277 (21.11)    1                                0.3714
                            ≥1 cup/d        534 (43.95)   625 (47.64)    1.127 (0.911--1.394)    0.2723   
                  AG/AA     \<1 cup/d       133 (10.95)   133 (10.14)    0.991 (0.733--1.341)    0.9542   
                            ≥1 cup/d        254 (20.91)   277 (21.11)    1.056 (0.823--1.355)    0.6691   
  rs10800901      AA        \<1 cup/d       131 (10.78)   118 (8.99)     1                                0.6906
                            ≥1 cup/d        246 (20.25)   265 (20.20)    1.115 (0.812--1.532)    0.5003   
                  GA/GG     \<1 cup/d       296 (24.36)   292 (22.26)    1.132 (0.833--1.540)    0.4277   
                            ≥1 cup/d        542 (44.61)   637 (48.55)    1.250 (0.938--1.665)    0.1276   
  ***ADORA2A***                                                                                           
  rs5760423       GG        \<1 cup/d       138 (11.36)   111 (8.46)     1                                0.8317
                            ≥1 cup/d        264 (21.73)   283 (21.57)    1.246 (0.910--1.706)    0.1699   
                  TG/TT     \<1 cup/d       289 (23.79)   299 (22.79)    1.282 (0.942--1.744)    0.1139   
                            ≥1 cup/d        524 (43.13)   619 (47.18)    1.352 (1.014--1.802)    0.0402   
  ***ADORA2B***                                                                                           
  rs17715109      GG        \<1 cup/d       381 (31.36)   360 (27.44)    1                                0.8732
                            ≥1 cup/d        712 (58.60)   817 (62.27)    1.130 (0.936--1.365)    0.2020   
                  TG/TT     \<1 cup/d       46 (3.79)     50 (3.81)      1.149 (0.738--1.786)    0.5389   
                            ≥1 cup/d        76 (6.26)     85 (6.48)      1.076 (0.753--1.536)    0.6878   
  rs2779212       TT        \<1 cup/d       252 (20.74)   226 (17.23)    1                                0.0336
                            ≥1 cup/d        494 (40.66)   555 (42.30)    1.187 (0.943--1.494)    0.1433   
                  CT/CC     \<1 cup/d       175 (14.40)   184 (14.02)    1.155 (0.870--1.534)    0.3182   
                            ≥1 cup/d        294 (24.20)   347 (26.45)    1.165 (0.906--1.497)    0.2345   
  ***ADORA3***                                                                                            
  rs3393          CC        \<1 cup/d       122 (10.04)   147 (11.20)    1                                0.5917
                            ≥1 cup/d        228 (18.77)   284 (21.65)    0.990 (0.725--1.350)    0.9477   
                  TC/TT     \<1 cup/d       305 (25.10)   263 (20.05)    0.731 (0.541-- 0.989)   0.0423   
                            ≥1 cup/d        560 (46.09)   618 (47.10)    0.856 (0.647--1.133)    0.2767   
  rs2786967       AA        \<1 cup/d       361 (29.71)   357 (27.21)    1                                0.2144
                            ≥1 cup/d        676 (55.64)   752 (57.32)    1.036 (0.856-- 1.255)   0.7152   
                  GA/GG     \<1 cup/d       66 (5.43)     53 (4.04)      0.771 (0.514-- 1.155)   0.2066   
                            ≥1 cup/d        112 (9.22)    150 (11.43)    1.257 (0.933--1.694)    0.1324   

^1^ Adjusted for age, marital status, income, education, smoking behavior, energy intake, systolic blood pressure, and BMI. ^2^ *p* for interaction.
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###### 

Risk of dyslipidemia depending on the coffee intake and genotype in ADORA gene family in female.

  Genes           Alleles   Coffee Intake   Healthy       Dyslipidemia   Adjusted Model ^1^              
  --------------- --------- --------------- ------------- -------------- ---------------------- -------- --------
  ***ADORA1***                                                                                           
  rs10800899      GG        \<1 cup/d       392 (29.47)   374 (35.93)    1                               0.2012
                            ≥1 cup/d        537 (40.38)   366 (35.16)    0.789 (0.643--0.968)   0.0233   
                  AG/AA     \<1 cup/d       179 (13.46)   167 (16.04)    0.989 (0.761--1.286)   0.9356   
                            ≥1 cup/d        222 (16.69)   134 (12.87)    0.705 (0.537--0.924)   0.0115   
  rs6701725       GG        \<1 cup/d       393 (29.55)   367 (35.25)    1                               0.3393
                            ≥1 cup/d        520 (37.10)   346 (33.24)    0.784 (0.636--0.966)   0.0225   
                  AG/AA     \<1 cup/d       178 (13.38)   174 (16.71)    1.031 (0.794--1.339)   0.8196   
                            ≥1 cup/d        239 (17.97)   154 (14.79)    0.758 (0.585--0.982)   0.0356   
  rs10800901      AA        \<1 cup/d       180 (13.53)   172 (16.52)    1                               0.3401
                            ≥1 cup/d        210 (15.79)   160 (15.37)    0.891 (0.656--1.210)   0.4956   
                  GA/GG     \<1 cup/d       391 (29.40)   369 (35.45)    1.008 (0.777--1.309)   0.9504   
                            ≥1 cup/d        549 (41.28)   340 (32.66)    0.727 (0.560--0.944)   0.0168   
  ***ADORA2A***                                                                                          
  rs5760423       GG        \<1 cup/d       194 (14.59)   173 (16.62)    1                               0.3188
                            ≥1 cup/d        224 (16.84)   149 (14.31)    0.836 (0.617--1.134)   0.2497   
                  TG/TT     \<1 cup/d       377 (28.35)   368 (35.35)    1.124 (0.869--1.456)   0.3736   
                            ≥1 cup/d        535 (40.23)   351 (33.72)    0.829 (0.641--1.073)   0.1539   
  ***ADORA2B***                                                                                          
  rs17715109      GG        \<1 cup/d       508 (38.20)   486 (46.69)    1                               0.7766
                            ≥1 cup/d        671 (50.45)   461 (44.28)    0.795 (0.662--0.956)   0.0146   
                  TG/TT     \<1 cup/d       63 (4.74)     55 (5.28)      0.903 (0.608--1.339)   0.6107   
                            ≥1 cup/d        88 (6.62)     39 (3.75)      0.500 (0.332--0.754)   0.0009   
  rs2779212       TT        \<1 cup/d       343 (25.79)   335 (32.18)    1                               0.8210
                            ≥1 cup/d        421 (31.65)   301 (28.91)    0.839 (0.671--1.049)   0.1226   
                  CT/CC     \<1 cup/d       228 (17.14)   206 (19.79)    0.943 (0.735--1.210)   0.6469   
                            ≥1 cup/d        338 (25.41)   199 (19.12)    0.645 (0.506--0.823)   0.0004   
  ***ADORA3***                                                                                           
  rs3393          CC        \<1 cup/d       179 (13.46)   163 (15.66)    1                               0.9277
                            ≥1 cup/d        247 (18.57)   157 (15.08)    0.776 (0.572--1.053)   0.1035   
                  TC/TT     \<1 cup/d       392 (29.47)   378 (36.31)    1.053 (0.809--1.370)   0.7011   
                            ≥1 cup/d        512 (38.50)   343 (32.95)    0.806 (0.618--1.051)   0.1109   
  rs2786967       AA        \<1 cup/d       486 (36.54)   444 (42.65)    1                               0.0308
                            ≥1 cup/d        617 (46.39)   411 (39.48)    0.818 (0.676--0.989)   0.0384   
                  GA/GG     \<1 cup/d       85 (6.39)     97 (9.32)      1.306 (0.939--1.816)   0.1125   
                            ≥1 cup/d        142 (10.68)   89 (8.55)      0.737 (0.542--1.002)   0.0515   

^1^ Adjusted for age, income, education, drinking and smoking behavior, energy intake, BMI, menopause, treatment of female hormone, Hypertension. ^2^ *p* for interaction.
